(Original title: Deuce (001323.SZ), the mattress brand with the largest domestic market share, plans to publicly issue 40.01 million shares of Oupai Home Furnishing as its largest customer)
Zhitong Finance APP news, Deuce shares (001323.SZ) disclosed the prospectus, the company plans to IPO 40.01 million shares, not less than 10% of the company’s total share capital after the issuance, and the total share capital after the issuance is 400.01 million shares. The preliminary inquiry date is June 8, 2022, and the subscription date is June 14, 2022.
The prospectus disclosed that the company is mainly engaged in the research and development, production and sales of healthy sleep systems. Its main products include mid-to-high-end mattresses, bed frames, bed products and other products, of which mattresses are the company’s core products. The “Mousse” brand has been deeply rooted in the hearts of the people, and the Mousse mattress ranks first in the domestic market.
During the reporting period, the company’s sales to OPPEIN (603833.SH) achieved rapid growth, with revenue of 62.8815 million yuan, 288 million yuan and 528 million yuan, accounting for 1.63%, 6.47% and 528 million of operating income respectively. 8.15%, OPPEIN is the company’s largest customer in 2020 and 2021. In addition, as of the signing date of this prospectus, OPAI Home Furnishings holds 1.5% of the issuer’s equity through its wholly-owned subsidiary OPIP Investment. In addition, the company’s shareholder list also includes Red Star Macalline (01528), Sequoia Jingyu, etc.
It is reported that the company’s net profits attributable to the company’s ordinary shareholders after deducting non-recurring gains and losses in 2019, 2020 and 2021 were 425 million yuan, 576 million yuan and 677 million yuan respectively. From January to March 2022, the company achieved operating income of 1.245 billion yuan, a year-on-year increase of 0.2%. The net profit attributable to shareholders of the parent company and the net profit attributable to the parent company after deducting non-recurring gains and losses were 124 million yuan and 124 million yuan respectively, a year-on-year decrease of 9.07% and 8.67%.
From January to June 2022, the company’s operating income is expected to be 2.95 billion to 3.15 billion yuan, a year-on-year increase of 5.02% to 12.14%. Net profit attributable to shareholders of the parent company is expected to be 310 million to 350 million yuan, a year-on-year change of -5.03% to 7.23%. Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses is expected to be 306 million to 346 million yuan, a year-on-year change of -4.78% to 7.67%.
The announcement shows that the company’s funds raised from this issuance will be invested in the following projects after deducting the issuance costs: 1.227 billion yuan for the construction project of the East China healthy bedding production line, 150 million yuan for the digital marketing project, and 100 million yuan for the healthy sleep technology research center Construction projects, totaling 1.477 billion yuan.